These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

524 related items for PubMed ID: 21212757

  • 1. Utility of fecal calprotectin in differentiating active inflammatory bowel disease from coexistent irritable bowel syndrome.
    Sprakes MB, Hamlin PJ, Ford AC.
    Am J Gastroenterol; 2011 Jan; 106(1):166; author reply 166-7. PubMed ID: 21212757
    [No Abstract] [Full Text] [Related]

  • 2. Diagnostic value of calprotectin in irritable bowel syndrome and in inflammatory bowel disease.
    Grad C, David L, Portincasa P, Dumitraşcu DL.
    Rom J Intern Med; 2012 Jan; 50(1):3-6. PubMed ID: 22788087
    [Abstract] [Full Text] [Related]

  • 3. [Measurement of calprotectin in faeces].
    Jahnsen J, Røseth AG, Aadland E.
    Tidsskr Nor Laegeforen; 2009 Apr 16; 129(8):743-5. PubMed ID: 19373299
    [Abstract] [Full Text] [Related]

  • 4. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H, Küppers B, Mickisch O, Baniewicz W, Drescher M, Traber L, Kempf A, Schmidt-Gayk H.
    Clin Lab; 2005 Apr 16; 51(3-4):117-26. PubMed ID: 15819166
    [Abstract] [Full Text] [Related]

  • 5. Faecal calprotectin: the case for a novel non-invasive way of assessing intestinal inflammation.
    Gearry R, Barclay M, Florkowski C, George P, Walmsley T.
    N Z Med J; 2005 May 06; 118(1214):U1444. PubMed ID: 15886739
    [No Abstract] [Full Text] [Related]

  • 6. FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.
    Kotze LM, Nisihara RM, Marion SB, Cavassani MF, Kotze PG.
    Arq Gastroenterol; 2015 May 06; 52(1):50-4. PubMed ID: 26017083
    [Abstract] [Full Text] [Related]

  • 7. [Calprotectin in feces a well-documented marker of gastrointestinal inflammation. Indicates disease intensity--normalization of values predict mucosal healing].
    Lasson A.
    Lakartidningen; 2015 May 06; 107(43):2645-9. PubMed ID: 21137533
    [No Abstract] [Full Text] [Related]

  • 8. Calprotectin testing in the community.
    Wassell J.
    Ann Clin Biochem; 2011 Jan 06; 48(Pt 1):1-2. PubMed ID: 21273635
    [No Abstract] [Full Text] [Related]

  • 9. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM, Trummler M, Seeholzer P, Criblez DH, Seibold F.
    Dis Colon Rectum; 2007 Oct 06; 50(10):1697-706. PubMed ID: 17762964
    [Abstract] [Full Text] [Related]

  • 10. Fecal markers: calprotectin and lactoferrin.
    Abraham BP, Kane S.
    Gastroenterol Clin North Am; 2012 Jun 06; 41(2):483-95. PubMed ID: 22500530
    [Abstract] [Full Text] [Related]

  • 11. Faecal calprotectin: a new marker for Crohn's disease?
    Wassell J, Dolwani S, Metzner M, Losty H, Hawthorne A.
    Ann Clin Biochem; 2004 May 06; 41(Pt 3):230-2. PubMed ID: 15117438
    [Abstract] [Full Text] [Related]

  • 12. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation?
    Keohane J, O'Mahony C, O'Mahony L, O'Mahony S, Quigley EM, Shanahan F.
    Am J Gastroenterol; 2010 Aug 06; 105(8):1788, 1789-94; quiz 1795. PubMed ID: 20389294
    [Abstract] [Full Text] [Related]

  • 13. Prospective evaluation of faecal neutrophil-derived proteins in identifying intestinal inflammation: combination of parameters does not improve diagnostic accuracy of calprotectin.
    Schröder O, Naumann M, Shastri Y, Povse N, Stein J.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):1035-42. PubMed ID: 17877510
    [Abstract] [Full Text] [Related]

  • 14. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease].
    van den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I.
    Ned Tijdschr Geneeskd; 2003 Nov 29; 147(48):2360-5. PubMed ID: 14677476
    [Abstract] [Full Text] [Related]

  • 15. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.
    Gisbert JP, McNicholl AG.
    Dig Liver Dis; 2009 Jan 29; 41(1):56-66. PubMed ID: 18602356
    [Abstract] [Full Text] [Related]

  • 16. Review of fecal biomarkers in inflammatory bowel disease.
    Sutherland AD, Gearry RB, Frizelle FA.
    Dis Colon Rectum; 2008 Aug 29; 51(8):1283-91. PubMed ID: 18543035
    [Abstract] [Full Text] [Related]

  • 17. Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.
    Kaiser T, Langhorst J, Wittkowski H, Becker K, Friedrich AW, Rueffer A, Dobos GJ, Roth J, Foell D.
    Gut; 2007 Dec 29; 56(12):1706-13. PubMed ID: 17675327
    [Abstract] [Full Text] [Related]

  • 18. [Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report].
    Krzesiek E, Iwańczak B.
    Pol Merkur Lekarski; 2010 Oct 29; 29(172):241-6. PubMed ID: 21207640
    [Abstract] [Full Text] [Related]

  • 19. Faecal lactoferrin--a novel test to differentiate between the irritable and inflamed bowel?
    Sidhu R, Wilson P, Wright A, Yau CW, D'Cruz FA, Foye L, Morley S, Lobo AJ, McAlindon ME, Sanders DS.
    Aliment Pharmacol Ther; 2010 Jun 29; 31(12):1365-70. PubMed ID: 20331581
    [Abstract] [Full Text] [Related]

  • 20. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease.
    Røseth AG, Aadland E, Grzyb K.
    Scand J Gastroenterol; 2004 Oct 29; 39(10):1017-20. PubMed ID: 15513345
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.